Cost-effectiveness of bilateral vs. single internal thoracic artery grafts at 10 years.
Little M. et al, (2022), Eur Heart J Qual Care Clin Outcomes, 8, 324 - 332
Costs of Joint Replacement in Osteoarthritis: A Study Using the National Joint Registry and Clinical Practice Research Datalink Data Sets.
Leal J. et al, (2022), Arthritis Care Res (Hoboken), 74, 392 - 402
Viscoelastic haemostatic assay augmented protocols for major trauma haemorrhage (ITACTIC): a randomized, controlled trial.
Baksaas-Aasen K. et al, (2021), Intensive Care Med, 47, 49 - 59
Enhanced recovery following hip and knee arthroplasty: a systematic review of cost-effectiveness evidence.
Pritchard MG. et al, (2020), BMJ Open, 10
The impact of the enhanced recovery pathway and other factors on outcomes and costs following hip and knee replacement: routine data study
Judge A. et al, (2020), Health Services and Delivery Research, 8, 1 - 188
The percentage of high-grade prostatic adenocarcinoma in prostate biopsies significantly improves on Grade Groups in the prediction of prostate cancer death.
Berney DM. et al, (2019), Histopathology, 75, 589 - 597
Impact of a national enhanced recovery after surgery programme on patient outcomes of primary total knee replacement: an interrupted time series analysis from "The National Joint Registry of England, Wales, Northern Ireland and the Isle of Man".
Garriga C. et al, (2019), Osteoarthritis Cartilage, 27, 1280 - 1293
Five-year costs from a randomised comparison of bilateral and single internal thoracic artery grafts.
Little M. et al, (2019), Heart, 105, 1237 - 1243
One-year costs of bilateral or single internal mammary grafts in the Arterial Revascularisation Trial.
Gray AM. et al, (2017), Heart, 103, 1719 - 1726
Costs, quality of life and cost-effectiveness of arthroscopic and open repair for rotator cuff tears
Murphy J. et al, (2016), BONE & JOINT JOURNAL, 98B, 1648 - 1655
COST-EFFECTIVENESS ANALYSIS OF PLERIXAFOR FOR STEM CELL MOBILIZATION FOR POOR MOBILIZERS IN CANADA
Rebeira M. et al, (2012), VALUE IN HEALTH, 15, A223 - A223
Cost-effectiveness of fingolimod compared to interferon beta-1a based on patient transitions in TRANSFORMS
Bergvall N. et al, (2012), JOURNAL OF NEUROLOGY, 259, S68 - S69
DISABILITY PROGRESSION IN PATIENTS WITH RELAPSING REMITTING MULTIPLE SCLEROSIS (RRMS) WHO EXPERIENCE DISEASE ACTIVITY DESPITE PREVIOUS DISEASE MODIFYING THERAPY
Hettle R. et al, (2011), VALUE IN HEALTH, 14, A318 - A318
A REVIEW OF EPIDEMIOLOGICAL LITERATURE ON THE BASIC REPRODUCTION NUMBER FOR THE 2009 NOVEL STRAIN OF H1N1
Walker A. et al, (2011), VALUE IN HEALTH, 14, A122 - A122